Cenuco (AMEX:ICU)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Cenuco Charts. Click Here for more Cenuco Charts.](/p.php?pid=staticchart&s=A%5EICU&p=8&t=15)
Ascendia Brands, Inc. (AMEX:ICU), formerly Cenuco, Inc.,
today announced that its AMEX ticker symbol will change from ICU to
ASB effective as of the opening of trading on Monday, May 15, 2006.
The new CUSIP number for Ascendia's common stock will be 043509 10 8.
No action is required on the part of stockholders.
The company's stockholders approved the name change at a Special
Meeting held on May 3, 2006 and it became effective as of May 9.
"The name change to Ascendia Brands is a further step in the
company's plan to build a strong market position around a series of
brands that consumers know and trust," said Joseph Falsetti,
Ascendia's President and Chief Executive Officer. "The Ascendia Brands
name will become synonymous with reliability, quality and value but
even more importantly, the Ascendia Brands name reflects what we stand
for - a belief and set of values that transcend every facet of our
business."
Ascendia's wireless applications development subsidiary will
continue to do business under the Cenuco name.
About Ascendia Brands
Ascendia Brands, Inc. is a leader in the value and premium value
segments of the health and beauty care (HBC) products sector. In
November 2005, Ascendia expanded its range of product offerings in the
HBC market through the acquisition of a series of brands, including
Baby Magic(R), Binaca(R), Mr. Bubble(R) and Ogilvie(R). The company is
headquartered in Lawrenceville, New Jersey. The company operates two
manufacturing and distribution facilities, in Binghamton, New York,
and Toronto, Canada. Visit us on the web at
http://www.ascendiabrands.com
For more information contact Elizabeth Houlihan at (609) 219-0930,
ext 139, ehoulihan@ascendiabrands.com
Forward Looking Statements
Certain statements contained herein may constitute forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933, 21E of the Exchange Act of 1934 and/or the Private Securities
Litigation Reform Act of 1995. Such statements include, without
limitation, statements regarding business plans, future regulatory
environment and approval and, the Company's ability to comply with the
rules and policies of independent regulatory agencies. Although the
Company believes the statements contained herein to be accurate as of
the date they were made, it can give no assurance that such
expectations will prove to be correct. The Company undertakes no
obligation to update these forward-looking statements.